Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-10-26

FDA Approved: MEROPENEM — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approves Fresenius Kabi USA, LLC's original application for Meropenem as an injectable generic antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Meropenem (Meropenem)

Snippet

ORIG AP for MEROPENEM (MEROPENEM)